[Preclinical results with 15-deoxyspergualin in experimental graft versus host disease].
The efficacy of 15-deoxyspergualin (15-DS) was tested in two models of experimental graft versus host disease (GvHD) in mice. In both models, which lead to a hemolytic anemia or to a glomerulonephritis respectively followed by subsequent death of the animals, 15-deoxyspergualin showed good therapeutic effects.